Product NDC: | 11584-0476 |
Proprietary Name: | Relagesic |
Non Proprietary Name: | Acetaminophen and Phenyltoloxamine Citrate |
Active Ingredient(s): | 650; 50 mg/1; mg/1 & nbsp; Acetaminophen and Phenyltoloxamine Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11584-0476 |
Labeler Name: | International Ethical Labs, inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19950916 |
Package NDC: | 11584-0476-1 |
Package Description: | 100 TABLET in 1 BOTTLE, DISPENSING (11584-0476-1) |
NDC Code | 11584-0476-1 |
Proprietary Name | Relagesic |
Package Description | 100 TABLET in 1 BOTTLE, DISPENSING (11584-0476-1) |
Product NDC | 11584-0476 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetaminophen and Phenyltoloxamine Citrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19950916 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | International Ethical Labs, inc. |
Substance Name | ACETAMINOPHEN; PHENYLTOLOXAMINE CITRATE |
Strength Number | 650; 50 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |